551-03-015 / 551-03-015 ISMRM Abstract

Linking MRI with Spatial Transcriptomics to Detect Molecular Alterations in Alzheimer’s Disease Mouse Brain

Primary: Diffusion - DWI/DTI/DKI

Secondary: Neuro - Alzheimer's Disease

551-03-015 · Advanced MRI Biomarkers of Brain Aging, Vascular Health, and Alzheimer’s Disease · Wednesday, 13 May, 4:00 PM–5:36 PM · Power Pitch Theatre 1

Keywords: Alzheimer's Disease Microstructure Diffusion MRI Quantitative Susceptibility Mapping (QSM) Spatial transcriptomics

Accepted

Xinyue Han¹, Jie Chen¹, Zhuoheng Liu¹, Juan Liu¹, Nataliya Tod¹, Nian Wang ^1,2

¹University of Texas Southwestern Medical Center, Dallas, United States of America

²Peter O'Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center, Dallas, United States of America

Presenting Author: Nian Wang

Synopsis

Motivation:

Goals:

Approach:

Results:

Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

References

1. Liu, C., Li, W., Johnson, G. A. & Wu, B. High-field (9.4 T) MRI of brain dysmyelination by quantitative mapping of magnetic susceptibility. Neuroimage 56, 930–938 (2011).

2. Wang, N. et al. Probing demyelination and remyelination of the cuprizone mouse model using multimodality MRI. Journal of Magnetic Resonance Imaging 50, 1852–1865 (2019).

3. Andica, C. et al. MR biomarkers of degenerative brain disorders derived from diffusion imaging. Journal of Magnetic Resonance Imaging 52, 1620–1636 (2020).

4. Le Bihan, D. Looking into the functional architecture of the brain with diffusion MRI. Nat Rev Neurosci 4, 469–480 (2003).

5. Shen, Y. et al. A spatial imaging-transcriptomics paradigm for deciphering the molecular basis of microscopic MRI in the normal brain and Alzheimer’s disease. Cell Rep 44, (2025).

6. Chen, J. et al. Detecting Beta-amyloid Plaque via Low Rank Based Orthogonal Projection and Spatial-spectrum Detector Using High-resolution Quantitative Susceptibility Mapping for Preclinical Studies. IEEE Trans Biomed Eng (2025).

7. Chen, W.-T. et al. Spatial transcriptomics and in situ sequencing to study Alzheimer’s disease. Cell 182, 976–991 (2020).

8. Zhou, T. et al. Microglial debris is cleared by astrocytes via C4b-facilitated phagocytosis and degraded via RUBICON-dependent noncanonical autophagy in mice. Nat Commun 13, 6233 (2022).

9. Lawrence, J. M., Schardien, K., Wigdahl, B. & Nonnemacher, M. R. Roles of neuropathology-associated reactive astrocytes: a systematic review. Acta Neuropathol Commun 11, 42 (2023).

10. Mi, W. et al. Cystatin C inhibits amyloid-β deposition in Alzheimer’s disease mouse models. Nat Genet 39, 1440–1442 (2007).

11. Sastre, M. et al. Binding of cystatin C to Alzheimer’s amyloid β inhibits in vitro amyloid fibril formation. Neurobiol Aging 25, 1033–1043 (2004).

12. Holz, A., Bielekova, B., Martin, R. & Oldstone, M. Myelin-associated oligodendrocytic basic protein: identification of an encephalitogenic epitope and association with multiple sclerosis. The Journal of Immunology 164, 1103–1109 (2000).

13. Robb, A. & Wessling-Resnick, M. Regulation of transferrin receptor 2 protein levels by transferrin. Blood 104, 4294–4299 (2004).

14. Lyoumi, S. et al. Increased plasma transferrin, altered body iron distribution, and microcytic hypochromic anemia in ferrochelatase-deficient mice. Blood 109, 811–818 (2007).

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/551-03-015